BackAcrivon Therapeutics Overview

Acrivon Therapeutics Other Liabilities

Latest other liabilities for ACRV: $0.

Get informed when a big investor buys or sells

+ Follow
Other Liabilities
$0.00

Peer average

Loading

Acrivon Therapeutics Other Liabilities History

Loading

Acrivon Therapeutics vs. peers: Other Liabilities Comparison

Loading

Acrivon Therapeutics Other Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Acrivon Therapeutics (ACRV) FAQ

The latest other liabilities for ACRV is $0 as of June 2026. In the prior-year period, the figure was $0. Investors often review this figure alongside Acrivon Therapeutics's historical trend and sector peers before judging valuation or financial health.

Over the past year, ACRV's other liabilities moved from $0 to $0. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Acrivon Therapeutics's operating scale or balance-sheet position.

A other liabilities figure of $0 for ACRV is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting ACRV's other liabilities ($0), review year-over-year change from $0, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.